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Abstract
Medication nonadherence has a deleterious effect on patients with chronic health
conditions, as it contributes to poorer health outcomes and increased healthcare spending. This
Doctor of Nursing Practice project sought to improve medication adherence in at-risk patients by
enhancing patient-provider communication and improving health literacy in a large, urban, safety
net hospital. Utilizing a multi-prong approach, patients were provided with a visual aid – a pill
card, in conjunction with the teach-back method, to improve systolic blood pressure (SBP),
diastolic blood pressure (DPB) and Hemoglobin A1c (HbA1c) over a 6-month period. Twentythree patients participated in the project. Participant demographics, attitudes towards the
intervention, and clinical indicators were analyzed. The project was well received by all who
participated. Key findings included patients finding the pill card easy to use and the teach-back
method helpful in learning more about their medications. All target clinical indices decreased:
SBP; DBP; A1C, in keeping with current positive findings on the use of triangulated methods
conducted with larger samples. This data demonstrates the need for future larger scale projects
to evaluate outcomes using these methods. This protocol has the potential to be utilized as a
foundational program for other safety net hospitals.
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Chapter 1
Introduction
Medication nonadherence is a common and expensive problem, affecting upwards of
50% of patients with chronic health conditions and is responsible for over 100,000 preventable
deaths and $100 billion in annual health care costs (Kleinsinger, 2018). This costly phenomenon
contributes to poorer chronic disease prevention and management, worse population health
outcomes and rising health care costs (Kleinsinger, 2018). Medication use and health care costs
have seen substantial increases over the past decade (Kleinsinger, 2018). In the US,
approximately seventy five percent of hospital outpatient clinic visits involve some form of
pharmaceutical (Watanabe, Mcinnis, &; Hirsch, 2018). This high prevalence of pharmacotherapy
as a means of chronic disease management necessitates a solution to the problem of nonadherence.
The World Health Organization (WHO) defines medication adherence as “the extent to
which a person’s behavior corresponds with agreed recommendations from a health care
provider.” (Sabaté, 2003). However; this is an oversimplified definition, as focus is implied
solely on the patient’s actions, when in reality adherence is not a one-dimensional problem.
Factors including the complexity of a medication regimen, timing of doses, side effects,
individual behaviors, costs of treatment, health literacy, and social factors must be taken into
account when developing an intervention (Costa et al., 2015). Medication adherence
interventions are often unifactorial, and as a result can fall short of remedy and sustainability.
When evaluating ways to effect change, a population level view of prescription use can
help inform clinical practice and guide interventions. In a National Health and Nutrition
Examination Survey analysis of prescription drug use from 2015-2016, nearly half of the US
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population had used at least one prescription drug in the past 30 days, and 85% of adults greater
than 60 use prescription drugs (Centers for Disease Control and Prevention, 2019). Twenty four
percent of US patients reported using three or more prescription drugs in the past 30 days and
12.6% had used five or more (Centers for Disease Control and Prevention, 2019). Highest
prescription use was found in non-Hispanic whites followed by non-Hispanic blacks and use was
lowest among non-Hispanic Asian and Hispanic patients (Centers for Disease Control and
Prevention, 2019). In total, 5.8 billion prescription drugs were ordered or provided to patients in
2018 and over two thirds of those prescriptions were for chronic diseases such as diabetes and
hypertension (IQVIA, 2019). However, despite initial prescribing, nearly 30% of new
prescriptions go unfilled and 50% of the time medications are taken incorrectly. Further, after
six months of being prescribed a medication for a chronic disease, a majority of patients fail to
take the recommended amount prescribed or stop treatment altogether (Center for Drug
Evaluation and Research, 2016).
Problem Statement
The problem of medication nonadherence is multifaceted, with suboptimal medication
adherence leading to higher rates of health care utilization alongside the development of new
secondary medical problems, resulting in further healthcare spending (Watanabe, Mcinnis, &
Hirsch, 2018).
Despite many available interventions, problems with adherence continue to persist. No
disease, type of drug, or type of therapy, whether chronic or acute, is immune to medication
nonadherence (Costa et al., 2015) WHO attributes medication non-adherence to five dimensions:
“social and economic factors, health care team and system related factors, condition related
factors, therapy related factors, and patient related factors” (Sabaté, 2003). It is a complex
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problem that in addition to behavioral factors, is related to “the disease itself, complexity and
duration of the treatment, possible adverse drug reactions, cost of treatment, and social factors
(Costa et al., 2015).” Multifactorial interventions are most effective, including those targeting
provider and systems level processes in addition to patient behaviors (Kleinsinger, 2018).
In order to develop an effective solution, a proper understanding of the complex nature of
the problem must occur and multiple dimensions should be targeted. The intervention should
consider the fact that many patients receiving care in safety net hospitals typically come from
lower socioeconomic status, have diverse cultural backgrounds which influence their health
beliefs, may lack English proficiency, and have lower health literacy (Agency for Healthcare
Research and Quality, 2018). This Doctor of Nursing Practice project developed and
implemented a multidimensional approach to improving medication adherence rates in at-risk
patients in a busy Internal Medicine (IM) practice within a large urban safety net hospital, with a
goal of improving health outcomes and decreasing costs.
Significance
Medication non-adherence incurs tremendous financial burden on the U.S. healthcare
system and negatively impacts health outcomes. Estimates of annual adjusted cost per person to
the U.S. economy for disease specific non-adherence vary widely; from $949 to $44,190 per
person, while all-cause non-adherence is $5271 to $52,341 (Cutler, Fernandez-Llimos, Frommer,
Benrimoj, & Garcia-Cardenas, 2018) Non-adherence is also directly linked to clinical outcomes,
contributing to 33-69% of hospital admissions, higher risk of adverse events and increased
mortality (Centers for Disease Control and Prevention, 2017). Medication adherence is an
essential component of chronic disease management, specifically for conditions such as
hypertension and diabetes. (Chisholm-Burns & Spivey, 2012)
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Chapter 2
Review of the Literature
Search Strategy
This review of the literature examines the factors contributing to medication nonadherence and strategies to improve adherence. An electronic search was conducted using
PubMed, CINAHL and EBSCO. Relevant search terms included “medication adherence” OR
“medication non-adherence” OR “medication compliance” AND “interventions” OR “strategies”
OR “protocol” AND “primary care” OR “internal medicine” AND “adult” AND “health
literacy” AND “safety-net” OR “Medicaid” OR “urban.” The search yielded 122 results. After
removing duplicates and screening records for exclusions, 23 full text articles were assessed for
relevance which yielded a total of 13 quantitative studies and 1 qualitative study ranging in dates
of publication from 1997-2020 (see Appendix A).
Literature Findings
The Institute of Medicine (IOM) Health Literacy report states “efforts to improve quality,
reduce costs, and reduce disparities cannot succeed without simultaneous improvements in health
literacy” (Nielsen-Bohlman,Panzer & Kindig, 2004 pp.xiii-xiv) This is especially true when
considering interventions to improve medication adherence (Nielsen-Bohlman, Panzer & Kindig,
2004). The report found that approximately ninety million Americans have inadequate literacy
skills to navigate the U.S. healthcare system (Nielsen-Bohlman, Panzer & Kindig, 2004). These
patients are more likely to have difficulty taking medications correctly, understanding
medication labels and instructions, and are at greater risk of worse clinical outcomes than those
with higher levels of health literacy (Bennett, 2008) This is particularly true for patients who also
lack English proficiency; research indicates that patients with lower English proficiency typically
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have worse health outcomes (Office of Disease Prevention and Health Promotion, 2020) Low
health literacy is common among patients with chronic conditions such as hypertension and
diabetes and is exacerbated by the complex medication regimens that typically accompany such
conditions (Rudd, 2007).
When assessing potential interventions to improve adherence for patients with low health
literacy, it is imperative to understand subtle preferences in knowledge acquisition. Psychology
and marketing research reveal that humans typically prefer pictures over text (Sansgiry, Cady &
Adamcik,1997) One approach for patients with low health literacy is the use of a visual aid that
they can refer to after their visit (Negarandeh, Mahmoodi, Noktehdan, Heshmat, &
Shakibazadeh, 2013). Studies show that pictorial aids are especially helpful for relaying
importance of therapy, medication administration timing, and side effects. (Sansgiry, Cady &
Adamcik,1997) Further, the use of pictures in combination with written and verbal information
seems to enhance retention of information (Katz, Kripalani & Weiss, 2006). Dowse and Ehlers
(2004) demonstrated this phenomenon in their randomized controlled trial of text only versus
text plus pictogram study design for a low-literate, mostly female population. The pictogram
group achieved an average of 95% understanding versus 70% for the control group (p<0.01).
More importantly, adherence improved significantly, by 90% in the text plus pictogram group
and 72% in the control group (p<0.01) (Katz, Kripalani & Weiss, 2006).
Kripalani et al., 2007 conducted a randomized controlled trial to develop, implement and
evaluate a “pill card”; a single page display of a patient’s daily medications that includes images
of pills and highly simplistic administration instructions. Researchers found that at 3 months
60% of patients were still using the pill card. Regular pill card use was significantly higher
among those with lower literacy skills, lower education levels, or patients who were cognitively
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impaired (p < 0.05). Further, 92% of participants understood how to use the tool, and 94%
reported the tool helped them remember information about their medications (Kripalani, et. al,
2007). A randomized controlled trial conducted by Negarandeh, Mahmoodi, Noktehdan,
Heshmat, & Shakibazadeh (2013), showed similar findings. Researchers paired 127 patients
with type II diabetes and low health literacy with a pictorial image alongside a teach back
method to improve adherence to medication and diet. Significant improvements in medication
knowledge and adherence were found in the intervention groups but not in control groups
(p<0.001).
The Agency for Healthcare Research and Quality (AHRQ) supports the use of pill cards
in clinical practice, arguing that pill cards are a simple way to visually demonstrate a patient’s
daily medication regimen. Via the use of pictures or icons, together with short phrases, patients
can easily see each medication, its indication, the amount to take, and frequency of doses. AHRQ
argues that this format is far easier for patients to comprehend than the typical complex and
lengthy instructions provided with prescriptions (Agency for Healthcare Research and Quality,
2018). Kripalani et. al, 2007 recommends grouping dosing instructions into the following four
time periods: morning, noon, evening and bedtime. The full medication schedule can be
displayed in table format including pictures of pills or icons, how many pills to take, and what
time of day the pills should be taken (Kripalani et al., 2007). Label formats can be enhanced by
clear headers, lists, and white space for ease of readability, with large print, and simple language
that avoids the use of medical jargon (Shrank, Avorn, Rolon, & Shekelle, 2007).
The evidence is promising for visual based aids and is even more compelling if a more
than one approach is used. In a systematic review of the literature conducted by Costa et. al,
2015, interventions relying on a single element were found unlikely to improve adherence. For
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example, interventions targeting patient education alone improved overall knowledge but
demonstrated no significant increase in adherence. However, when interventions incorporated
more than one element, adherence and clinical outcomes were more likely to improve (Costa et.
al, 2015). Additionally, the notion that adherence is influenced by the level of risk patients
associate with a particular medication was a common theme among studies included in the
review. Findings support the importance of communication by healthcare providers in order for
patients to make informed decisions. Milosavljevic, Aspden & Harrison, 2018, had similar
conclusions, the most effective interventions were multifaceted, focused and personalized, and
had a combined emphasis on regimen simplification and communication between patient and
provider.
Patient and provider communication is especially important if a patient overestimates the
risk of taking a particular medication. One method to improve accuracy of communication
relayed between patient and provider is the teach back method. Using this method, patients are
asked to repeat back what they understood from the instructions provided by their health care
practitioner and the intervention is well suited for patients with lower health literacy (Agency for
Healthcare Research and Quality, 2017 & Bickmore, Pfeifer & Paasche-Orlow, 2009). Via this
approach, health care providers can individualize teaching and reassess the patient’s level of
comprehension. This method is well studied, its effects well documented, and is recommended as
a “top patient safety practice” by the National Quality Forum (2010).
Experts recommend treating all patients as though they could have trouble understanding
instructions, as only twelve percent of patients have a level of health literacy adequate to
interpret medical information, and even these patients’ amount of comprehension can be
adversely affected by illness or stress (Agency for Healthcare Research and Quality, 2020).
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AHRQ recommends a “universal precautions” approach to health literacy for every patient, as it
would be unrealistic to evaluate each individual’s level of comprehension at any given time
(2020). Approaches to universal precautions should include simplified language, confirmation
of comprehension and positive reinforcement of the patient’s motivation to change their behavior
(Agency for Healthcare Research and Quality, 2020).
Interventions that are multifaceted, pictorially based, and emphasize communication
between patient and provider show clear benefit. Medication adherence lowers health care costs,
reduces length of inpatient hospital stays, and reduces emergency department utilization
(Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011). Using claims data over a three-year
period extracted from one of the largest pharmacy benefits managers, researchers measured
health services use of 135,008 patients and compared that information with the same patients’
level of medication adherence (Roebuck, Liberman, Gemmill-Toyama, & Brennan, 2011). The
study demonstrated a significantly lower length of stay for inpatient hospitalizations in the
adherent group. Emergency department utilization was also lower in the adherent group with
0.01-0.04 visits less than non-adherent patients. Adherence also demonstrated significant
reductions in total healthcare spending, with annual savings per patient in the amount of “$7,823
for heart failure, $3908 for hypertension, $3756 for diabetes and $1258 for dyslipidemia”
(Roebuck, Liberman, Gemmill-Toyama, &amp; Brennan, 2011).
While adherence can increase medication expenditures, it lowers overall medical costs.
For every dollar spent on medications, the return on investment (ROI) ranges from $1.25 to $37
depending on the type of medication (Roebuck, Liberman, Gemmill-Toyama, &amp; Brennan,
2011). One study’s findings demonstrated that for every $177 spent on diabetes pharmaceuticals,
there was a $1251 savings in disease-related costs, netting a per patient savings of $1074,
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averaging a ROI of 7.1:1; while for hypertension and hypercholesterolemia, the average ROI for
the same percentage increase in pharmaceutical use was 4.0:1 and 5.1:1, respectively (Sokol,
Mcguigan, Verbrugge, &amp; Epstein, 2005). Results of health outcomes studies also back these
figures, for example, in a study examining risk of fracture in osteoporotic patients, those who
were at least 80% adherent to their medications had a 26% reduction in fracture risk (Siris et al.,
2006). Improved medication adherence has also been forecasted to result in $1000-$7000 in
annual per-patient savings depending on the patient’s disease state (Roebuck, Liberman,
Gemmill-Toyama, &amp; Brennan, 2011).
Disease related cost reduction must also be acknowledged, as increased medication
adherence has an inverse relationship to disease related medical expenses. In a retrospective
cohort study using claims data from 137,277 patients, statistically significant (p<0.05)
associations were found between higher levels of adherence and lower disease related medical
costs in patients with hypercholesterolemia and diabetes (Sokol, Mcguigan, Verbrugge, &amp;
Epstein, 2005). For both conditions, total healthcare costs also decreased with higher levels of
adherence, with the most reduction in costs seen for patients with 80-100% adherence (Sokol,
Mcguigan, Verbrugge, &amp; Epstein, 2005). In the same study, statistically significant
decreases in hospitalization risk were found in the adherent group (p <0.05), and all-cause costs
were reduced, despite increased drug costs (Sokol, Mcguigan, Verbrugge, &amp; Epstein, 2005).
Cost of the intervention itself must also be taken into consideration. The aforementioned
interventions are implementation friendly as they are relatively simple, inexpensive, and require
few resources. For interventions such as the use of a pill card, AHRQ offers a free template; all
that’s needed is a computer, a printer, and the medication information to be included on the final
product (Agency for Healthcare Research and Quality, 2020). As the literature suggests, the
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final intervention should address more than one dimension. A teach back strategy could be
combined with pill card use to improve success of the intervention. The teach back method is
simple and should not add a significant amount of time to patient encounters (Merck, 2014). The
medication is explained, the patient is asked to repeat back how they will perform the treatment
or take the prescribed medication, and then an assessment is made of the patient’s level of
understanding (Agency for Healthcare Research and Quality, 2017). In addition to the pill card
template, AHRQ offers a teach-back “quick start” guide for clinicians and has free resources for
both patients, clinicians, and practice staff to support implementation (2020).
Project Model
Incorporation of an evidence-based practice model of implementation helped define the
clinical question, select and evaluate the evidence, translate the evidence into practice, and
evaluate outcomes (Parkosewich, 2006). Rosswurm and Larrabee outline a six-step process to
help users synthesize empirical and contextual evidence with a goal of guiding implementation
of evidence-based interventions (Rosswurm & Larrabee, 1999). Steps included: “1) assessing
the need for change 2) Linking the problem with interventions and identifying the outcomes 3)
synthesizing evidence from the literature 4) developing a practice change 5) implementing and
evaluating the practice change, and 6) integrating and maintaining the practice change”
(Rosswurm & Larrabee, 1999). The model also encourages users to consider that clinical data is
not the sole metric guiding changes in practice, that clinicians should consider patient
satisfaction and preferences when identifying areas needing improvement
(See Appendix C) (Parkosewich, 2006).
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Supporting Theoretical Framework
A theoretical framework can help identify key factors that can either hinder or facilitate
adoption of an intervention (Amico, Mugavero, Krousel-Wood, Bosworth, &amp; Merlin, 2017).
For purposes of this project, the Health Belief model provided relevant constructs, including “the
level of accurate information about or knowledge of the disease; the role of treatment and the
specifics about following the treatment recommended; awareness or some sense of need for the
treatment; motivation to adhere; and a skill set needed to execute adherence behavior across
diverse situations and settings” (Amico, Mugavero, Krousel-Wood, Bosworth, &amp; Merlin,
2017). The Health Belief Model suggests that patient behaviors are influenced by the
simultaneous occurrence of patient’s (1) adequate concern about their condition (2) belief that
they are susceptible to poor health outcomes related to their condition (perceived threat) and (3)
the belief that following a particular recommendation could mitigate the perceived threat at an
acceptable social or financial cost (Rosenstock, Strecher & Becker, 1988) Assessing educational
needs can fortify implementation planning and should take into consideration the extent to which
patients believe they can adequately execute a recommended action (Rosenstock, Strecher &
Becker, 1988).
Project Goal
The goal of this project was to develop and implement a multidimensional approach to
improving medication adherence in high-risk patients at a busy IM practice within a large urban
safety net hospital, and aimed to reduce health disparities, improve health outcomes, and
decrease costs.
Project Aims:
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1) To develop a medication adherence protocol to reduce levels of Hemoglobin A1c (HbA1c),
systolic blood pressure (SBP) and diastolic blood pressure (DBP) each by 25% over a 6month period in at-risk patients enrolled in an IM practice in a large urban safety net hospital
using universal precautions for health literacy.
2) To implement the medication adherence protocol and evaluate.
3) To make recommendations for scaling and sustainability throughout the rest of primary care
with a goal of using the protocol as a model for other safety net hospitals.

12

Chapter 3
Methods
Description and Approach to Aims
This quality improvement project sought to develop and implement a multidimensional
approach to improving medication adherence rates in at-risk patients in a busy IM practice within
a large urban safety net hospital, with a goal of reducing health disparities, improving health
outcomes and decreasing costs. The project utilized a medication visual aid in conjunction with
the teach back method in order to reduce HbA1c, SBP, and DBP. Information gleaned from this
project will be used to help guide future clinic practices. The project aims and methods are
described in this chapter.
The aims are as follows:
1. To develop a medication adherence protocol to reduce levels of HbA1c, SBP and
DBP by 25% over a 6-month period in at-risk patients enrolled in a general internal
medicine practice in a large urban safety net hospital using universal precautions for
health literacy.
2. To implement the medication adherence protocol and evaluate outcomes.
3. To make recommendations for scaling and sustainability throughout the rest of
primary care with a goal of using the protocol as a model for other safety net
hospitals.
Aim 1
To develop a medication adherence protocol to reduce levels of HbA1c, SBP and DBP by 25%
over a 6-month period in at-risk patients enrolled in an IM practice in a large urban safety net
hospital using universal precautions for health literacy.
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•

The Agency for Healthcare Research and Quality’s (AHRQ) quick start teach-back and
pill card templates were adapted for use at the safety net hospital’s IM practice.
o The teach-back tool provided an easy-to-use framework to facilitate adoption of
the teach-back method. Leadership was approached including the IM director and
pharmacy lead to solicit buy-in and teach-back champions were identified to
provide much needed support and enthusiasm for the project and to encourage
colleagues’ continuity with the protocol. The AHRQ pill card template offers a
framework to provide patients with a visual aid of what medications they are
taking and when they are taking them, allowing them to have all the information
they need in a one page easy to read format.

•

Criteria were created for the target audience.
o Eligible patients had a HbA1c >8 if over age 65, or a HbA1c >7 if under age 65
and/or a blood pressure reading of >150/90 mm Hg if over age 60 without a
diagnosis of diabetes or chronic kidney disease, and/or a blood pressure reading
of >140/90 mm Hg if over age 60 with a diagnosis of diabetes or chronic kidney
disease (CKD) or any patient aged 18-59 with no known major comorbidities.
This eligibility criteria are consistent with goals set out by the American Diabetes
Association, the American Heart Association and the American College of
Cardiology, to prevent complications that arise from poorly controlled blood
pressure and blood glucose (American Heart Association, 2020 & Journal of the
American College of Cardiology, 2018 & American Diabetes Association, 2018).

•

Information was gathered from key stakeholders.

14

o The director of IM and pharmacy lead were asked to identify what has worked in
the past to combat medication non-adherence, what has not worked, and why, in
order to avoid redundancy in project efforts and to proactively infer potential
barriers to project adoption.
•

The medication visual aid was created.
o Suggested columns from the AHRQ pill card template were used to create the
visual aid. Columns included: name of medication and dose, what the medication
is used for, instructions on how to take the medication, and timing of dose
delineated as morning, afternoon, evening, and nighttime. The information was
displayed in chart format with a check mark under the corresponding dose timing
for each medication (see Appendix E).

•

AHRQ’s one page teach-back handout describing how to perform teach-back with
patients was printed in anticipation of use by IM providers, nurses, and pharmacy liaisons
(see appendix F).

Aim 2
To implement the medication adherence protocol and evaluate outcomes.
•

At-risk patients were identified using a practice-wide report generated by the EMR that
displays data based on filtered results to capture any patient with a HbA1c >8 if over age
65, or a HbA1c >7 if under age 65 and/or a blood pressure reading of >150/90 mm Hg
in any patient over age 60 without a diagnosis of diabetes or chronic kidney disease,
and/or a blood pressure reading of >140/90 mm Hg in any patient over age 60 with a
diagnosis of diabetes or chronic kidney disease (CKD) or any patient aged 18-59 with no
known major comorbidities.
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•

A plan was made to prepare and train staff. Due to Covid constraints this protocol was
followed by one provider and not multiple providers as originally planned. The training
and protocol were as follows:
o Medical assistants would receive a one-page handout detailing how to review the
patient’s chart for an “intervention eligible” flag at the beginning of an encounter.
A hands-on activity would be employed utilizing steps detailed in the one-page
handout, including having the medical assistant open a test patient’s chart to
evaluate the patient’s “chart review tab” within the EMR to see if an updated
medication visual aid was currently in use. If not in use, the medical assistant
would notify the provider using a color-coded reminder on the door of the
patient’s room for the provider and RN to see, so they could begin use of the new
medication visual aid and teach back protocol.
o Medical providers, pharmacy liaisons and RNs would receive the AHRQ one
page teach-back handout detailing how to perform teach-back with patients, along
with a blank medication visual aid to fill out in real time. Teach back training
would be performed for all providers and staff using real time demonstration with
role play between patient and provider. Standardized scripts would be used for
each training session (see Appendix G).

•

Implement the intervention.
o Key Steps of the implementation process included:
1. The provider identifying patients in need of a medication visual aid
2. The Provider filling out the medication visual aid and performing teach back
with the patient.
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3. The provider verifying the patient’s home address and mailing the pill card to
the patient.
There were weekly audits of charts by the provider to ensure patients had not had
any adjustments to their medications by another provider since receipt of their last
pill card. If changes had been made, the patient was contacted to re-perform
teach back and a revised pill card was mailed to the patient’s home.
o At the end of 6 months, data from the EMR was used to identify patients who had
received the medication visual aid. Pre and post HbA1c, SBP and DBPs on
patients who received the visual aid and teach-back protocol were compared and
documented (as HbA1c is part of a patient’s routine screening every three months,
no labs were ordered or drawn for this protocol). Patients were contacted via
patient portal “Mychart” accounts or by phone call (for those who did not have
access to a computer, smartphone or Mychart) to complete a post intervention
survey in the form of a Likert scale (see appendix H).
o Data was recorded into tables for BP, HbA1c, age, gender and ethnicity.
Univariate analysis was used to show the number of patients with a BP and/or
HbA1c out of goal. Paired t tests were used to determine if a statistically
significant difference existed pre and post- intervention. Alpha was set at 0.05.
Aim 3
To make recommendations for scaling and sustainability.
a. Results and recommendations were disseminated to senior leadership, highlighting the
benefits of the protocol in the IM rollout.
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b. Implementation of staff training and protocol were recommended for geriatrics and
family medicine departments.
c. To encourage continued use and sustainability, it was recommended to incorporate the
protocol into provider dashboards (dashboards are routinely used to follow provider
compliance with population health-related activities and are their use is commonplace in
hospital outpatient clinics).
Implications
Medication adherence directly affects chronic disease treatment success. Implications of
this project on adherence rates were wide ranging from the effects on patient outcomes such as
reductions in mortality and morbidity to benefits to the health care system (Jimmy & Jose, 2011).
A combination of team-based care, patient education, reduced barriers, and use of a visual aid to
enhance patient/provider communication during and after the encounter provided a framework
for success (Neiman et al., 2018). Further, offering cost effective solutions which can be applied
to a wide variety of patients and settings, along with an understanding of the root causes of the
problem was also vital to the intervention’s effectiveness and its long-term impact. (Neiman et
al., 2018). The project predicted that patients who received the new medication visual aid and
teach back would have improved BP and HbA1c measurements. The goal was to have a userfriendly protocol that added minimal time to the patient encounter while simultaneously creating
a culture shift normalizing the new workflow. The project provided a useful framework for other
clinics and/or safety net hospitals to improve their rates of adherence.
IRB Considerations
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The Yale University IRB guidelines deemed this a Quality Improvement Project.
Participant information was de-identified, and the project was designed to maximize benefit and
minimize risk.
Project Timeline
Week 1:

Identify at risk patients using practice dashboards

Weeks 2-3:

Prepare for patient contact

Weeks 4-27: Go-live/Implementation
Week 28:

Send out post intervention patient surveys

Week 29:

Evaluate Pre and post HbA1c and BP on patients who received the intervention
and use descriptive statistics to describe population using tables

Weeks 30-31: Statistical analysis in consultation with a statistician
Return on Investment
The business case for this project was supported via an evaluation of the return on
investment (ROI). The project recommended use of a medication visual aid alongside an
increase of provider, nurse and pharmacy teach-back during patient encounters. The intervention
involved staff training on the incorporation of the Agency for Healthcare and Research Quality’s
free quick start teach-back guide and pill card templates. Training was scheduled to occur during
regularly scheduled, weekly, hour-long practice meetings, so no loss in revenue for the hour
would occur. Further, participant’s time did not need to be accounted for, as the hour-long
weekly meeting is a standing meeting, already built into staff schedules. Total costs for the
project were under $300, allowing for a low cost/high yield intervention.
This project served as a pilot for a long-term goal of reduced 30-day readmissions for all
diabetic patients. Readmissions for hypertension are not included in the analysis as national data
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on incidence of 30-day readmission rates for hypertension is lacking (Kumar et al., 2019). For
purposes of this ROI evaluation, a diabetic readmission will include inpatient adults > 18 years
of age with a primary or secondary diagnosis of diabetes. Given the safety net’s annual 30-day
diabetes readmission rate of 1947 patients, multiplied by the average cost of a 30-day
readmission ($15,200), amounts to $29,594,400 in wasteful spending annually (Agency for
Healthcare Research and Quality, 2021).
Data will be reviewed at the end of 1 year to evaluate whether or not patients had
decreased readmissions for diabetes. Direct savings will include a conservative target reduction
of 1% of the safety-net’s annual 30-day readmissions for diabetes, totaling $295,944. Indirect
benefits such as the potential for fewer complications, and patient and provider satisfaction
should also be noted, though they are not included in the ROI breakdown. This project will
enhance quality while lowering cost, achieving the IHI Triple aim of “improving the patient
experience of care, including quality and satisfaction, improving the health of populations, and
reducing the per capita cost of health care” (Institute for Healthcare Improvement, 2021).

20

Chapter 4
Results
A total of twenty-three patients with blood pressure and/or blood sugar measurements
above goal were enrolled in the project. Fifteen patients completed the project. With a total
sample size of n = 15, the average age was 54.6 yrs. (SD = 15.2). (Table 1). Gender breakdown
was 53.3% Male and 46.7% Female (Table 2). Race and ethnicity of participants comprised:
33% White, 20% Hispanic, 13% African, 27% African American, and 7% Portuguese (Figure 1).
This ethnic breakdown mirrors that of the safety-net’s overall population.
Statistical analysis was conducted in conjunction with a statistician. Descriptive and
frequency statistics were used to describe the demographics of the sample. Normality of
continuous variables was assessed using Shapiro-Wilk tests. Analyses were performed using
SPSS Version 28 (Armonk, NY: IBM Corp.,date).
Statistical Results
Normality was met for the BP observations and could not be computed for the A1c
analysis. SBP and DBP observations were normally distributed, so paired t-tests were used
(Table 3). Means and standard deviations for each observation of each outcome can be seen in
Table 4. There were no significant changes in systolic BP, t(12) = 2.03, p = 0.07, diastolic BP,
t(12) = 1.06, p = 0.31, or A1c, t(1) = 0.85, p = 0.55 (Table 5).
Findings on Clinical trends and Program evaluation
Despite a lack of statistically significant changes in any of the outcome measures, other
data endpoints support the use of this protocol. Most importantly, all target clinical indices
(SBP, DBP and HbA1c) decreased (Table 5).

21

Additionally, patients received a post-intervention survey in the form of a Likert scale, where
respondents were asked to rate the intervention in 5 different domains on a scale of 1-5 with 1 =
Agree strongly 2 = Agree, 3 = Unsure, 4 = Disagree, 5 = Disagree Strongly. Questions included:
•

Did you find the program useful?

•

Did you like using the pill card?

•

Did you like having your medication instructions relayed back?

•

Did the program help you understand what conditions your medications are for?

•

Did the program help you understand how to take your medications correctly?

Survey results demonstrated a majority of patients found the intervention useful, liked the pill
card and teachback methods, felt the program helped them understand their medical conditions
and how to correctly take their medications (Figure 2)
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Chapter 5
Discussion and Conclusion
This quality improvement project successfully implemented a health literacy forward
medication adherence intervention in a large inner city safety net hospital resulting in decreased
levels of SBP, DBP and HbA1c over a 6-month period. Key findings included decreases in all
target clinical indices and an overall positive reaction from participants. Improvement in selfefficacy and knowledge of one’s disease state must also be noted. Elements crucial to the
intervention’s success included user-friendly, easy to comprehend materials that were tailored to
each patient. Overall, the two approaches to medication adherence used in this project had
positive effects, though not statistically significant. Future work should include a robust sample
size, longer follow-up period, and allow for adequate resources to be allocated to the
implementation to ensure fidelity to the intervention.
Impact of the Covid-19 Pandemic
The medication adherence protocol initially involved preparing and training staff and developing
an implementation team. Due to unforeseen circumstances resulting from the covid-19
pandemic the ability of the proposal to be executed as planned was limited.
Limitations
The protocol was unable to be carried out as proposed due to limitations resulting from the
pandemic including: staff furloughing, turnover, scarcity of resources and decreased access to inperson encounters with many visits turning virtual. This presented challenges in data collection
and patient outreach as actions were carried out by a sole provider. Executing a quality
improvement process of this magnitude with one provider is not practical in most clinical
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settings. Given the multiple competing priorities typically encountered by staff in a safety-net
hospital it would not be feasible to replicate a similar approach to implementation in other
settings. Other limitations included having a small sample size which likely influenced statistical
significance. Additionally, some of the safety net’s populations including Asian,
Hawaiian/Pacific Islander, American Indian/Native American, and Middle Eastern, were not
represented in the sample limiting generalizability of findings. Having the same provider who
performed teach back also administer the post-intervention survey could have influenced
patient’s survey responses.
Future Research
Data from this project highlights the need for future quality improvement work in medication
adherence initiatives. Future work should focus on larger samples and leverage use of the EMR
and ancillary staff for a hybrid, interdisciplinary approach to the intervention to account for
workforce limitations typical to the safety net environment. Interventions should be iterative and
utilize a universal precautions approach to health literacy. It would be beneficial to examine
effects of the teach back method and pill card use on other outcomes including hospitalizations,
health related quality of life, and knowledge retention in addition to those examined in this
project.
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Appendix A:

Identifation

Adapted PRISMA Flow Diagram for DNP Project ROL

Additional records identified
through other sources
(n = 6)

Records identified through
database searching
(n = 122)

Eligibility

Screening

Records after duplicates removed
(n =67)

Records screened
(n = 67)

Records excluded
(n = 44)

Full-text articles
assessed for relevance
(n = 23)

Included

Studies included in ROL
(n =13)

Studies included in
matrix
(n =8)

From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009). Preferred Reporting Items for Systematic
Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med 6(7): e1000097. doi:10.1371/journal.pmed1000097
For more information, visit www.prisma-statemen
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Appendix B:
Project Model

Review literature for
effective
interventions with a
focus on health
literacy

Roll out finalized
protocol practice
wide, evaluate
process and
outcomes
intermittently,
review outcomes
with leadership,
internal medicine
department, and
pharmacy to
highlight program
successes

Synthesize &
appraise evidence
and assess
feasibility of
implementation
within the safety-net
model and current
culture

Pilot the protocol,
review process
and metrics/
outcome
measurements
Evaluate process
and make
changes where
needed

Develop medication
adherence protocol,
define timeline,
identify providers to
pilot intervention

A model of Evidence Based Practice Change. Larrabee, J.H., (2009) Nurse to Nurse Evidence Based Practice. New
York, McGraw-Hill
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Appendix C: Medication Visual Aid

Name: Sarah Smith
Pharmacy phone number: 123-456-7890
Name

Simvastatin
20mg

Used For

Cholesterol

Instructions

Date Created: July 5, 2021

Morning

Take 1 pill
at night

Take 2 pills
in the
morning
and 2 pills
in the
evening
Inject 24
units
before
breakfast
Diabetes
and 12
(Sugar)
units
Insulin
before
70/30
dinner
(Agency for Healthcare Research and Quality, 2020)
Furosemide
20mg

Fluid
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Afternoon

Evening

Night

Appendix D: Provider, RN and Pharmacy Liaison Teach-back Handout

Teach-Back Quick Guide
→ Use teach-back for ALL patients.
→ Start with most important message.
→ Limit to 2-4 key points.
→ Use plain language.
→ Rephrase message until patient demonstrates clear understanding.

Examples of Teach-Back Starters
→ “Just to be safe, I want to make sure we are on the same page. Can you

tell me…”
→ “I want to make sure that I explained things clearly. Can you explain to
me…”
→ “Can you show me how you would use your inhaler at home?”
Use Plain Language
Use these words
reduces swelling
blood thinner
take before meals
take after meals

Avoid these words
anti-inflammatory
anticoagulant
take on an empty
stomach
take on a full stomach

high (low) blood sugar hyper(hypo-)glycemic

Use these words
heart doctor
skin doctor
doctor who treats
diabetes
stomach doctor;
doctor for digestion
problems

Avoid these words
cardiologist
dermatologist

doctor for women

gynecologist

endocrinologist
gastroenterologist

fats

lipids

doctor for the brain,
spine, and nervous
system
cancer doctor

overweight

obese

eye doctor

ophthalmologist

weak bone disease

osteoporosis

pulmonologist

not cancer

benign

lung doctor
joint, bone, and
immune system doctor

high (low) blood
pressure

hyper(hypo-)tension

neurologist
oncologist

rheumatologist

Learning Objectives:
•

Staff understands the goal of using the teach-back method and how the teach-back
process is to be conducted.

•

Staff will be able to perform a live demonstration of a teach back interaction

https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-familyengagement/pfeprimarycare/TeachBack-QuickGuide-card.pdf
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Appendix E: Role Playing Scripts

Teach-Back
Role Play Scenario 1

Facilitator Instructions
1. As facilitator, play the role of the patient.
2. Request a volunteer to play the role of the clinician. The clinician will engage in teachback with the patient.
3. Provide the volunteer and the training group with information about the scenario. Page
2 contains the basic patient information.
4. Read silently the additional patient information (page 3) to be able to respond to the
volunteer during the role play.
5. Role play the scenario with the volunteer. Assume that the clinician has told the patient
the plan of care and the visit is now ending. Ask the volunteer to engage in teach-back to
ensure the patient understands.
6. As the patient, react to the clinician’s tone, message, and body language in the same way
you might if you were the patient.
7. Using the discussion prompts (page 3), engage the training group in a learning
discussion on what went well and what could be improved.

The Guide to Improving Patient Safety in Primary Care
Settings by Engaging Patients and Families
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https://www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-familyengagement/pfeprimarycare/teach-back-role-play-final508.pdf
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Appendix F
Patient Post Intervention Survey

Please place a check mark in the column that corresponds best with your answer for
each question
Agree
Agree
Strongly

Unsure

I found this program
useful
This program helped
me understand which
health conditions my
medications are for
This program helped
me understand how
to take my
medications correctly
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Disagree

Disagree
Strongly

Tables

Table 1. Age (n = 15)
N
Mean
Statistic Statistic
15
54.60
15

Age
Valid N
(listwise)
Table 2. Gender

Frequency
Male
Female
Total

Percent
8
53.3
7
46.7
15
100.0

Table 3. Paired Samples Test

Pair 1 Pre SBP - Post
SBP
Pair 2 Pre DBP - Post
DBP
Pair 3 Pre A1c - Post
A1c

t
2.028

Significance
Two-Sided
df
p
12
.065

1.062

12

.309

.849

1

.552
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Table 4. Means and Standard Deviations
Outcomes

Pre-intervention

Post-intervention

M (SD)

M (SD)

Systolic BP

148.23 (13.36)

136.62 (15.68)

0.65

Diastolic BP

87.38 (13.94)

83.08 (12.51)

0.31

A1c

10.90 (4.38)

8.65 (0.64)

0.55

p-value

Table 5. Decrease in Clinical Indices
Outcomes

Pre-intervention

Post-intervention

M (SD)

M (SD)

Systolic BP

148.23 (13.36)

136.62 (15.68)

Diastolic BP

87.38 (13.94)

83.08 (12.51)

A1c

10.90 (4.38)

8.65 (0.64)
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Figures
Figure 1. Race/Ethnic Breakdown

% Breakdown

African American

White

African

Hispanic/Latino

Portuguese

Figure 2. Post Intervention Survey

Post Intervention Patient Survey
14
12
10
8
6
4
2
0
Agree Strongly

Agree

Unsure

Disagree

Disagree Strongly

I found this program useful
I liked the pill card
I liked having my medication intstructions relayed back to me
This Program helped me understand which health conditions my medications are for
This program helped me understand how to take my medications correctly
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